Veru, Inc.

Stock ticker:
VERU

On November 10, 2022, Veru. Inc.’s stock price plunged by over 55% in mid-morning trading after a Food and Drug Administration Advisory Committee voted against recommending Emergency Use Authorization for the Company’s Covid-19 pill VERU-111.

Download Complaint

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.